Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Alzheimer Disease
Kurve Technology reports clinical success in Alzheimer disease study
October 25th, 2006
Kurve Technology, Inc., a leader in nasal drug-delivery devices, announced the delivery of insulin by the ViaNase electronic atomizer significantly improved memory in patients with Alzheimer disease (AD) or Amnestic Mild Cognitive Impairment. In a recent study presented at the International Conference on Alzheimer's Disease by investigators from the [U.S.] Veterans Affairs (VA) Puget Sound Health Care System in Seattle, Washington and the University of Washington School of Medicine, ViaNase intranasally delivered insulin or placebo to 24 study participants. Treatment was well-tolerated, with no serious adverse events or changes in plasma glucose or insulin...
Source: Biotech Week (2006-10-25)
|
